Sorry, you need to enable JavaScript to visit this website.

Pediatric VTE & Post-Fontan | XARELTO® (rivaroxaban) HCP
Pediatrics hero

Pediatric VTE and post-Fontan care are complex.1,2

Helping protect against thrombosis doesn’t have to be.

FDA APPROVED with 2 indications in pediatric patients3

XARELTO®: the direct oral anticoagulant (DOAC) studied in the largest clinical trials for pediatric VTE treatment and prevention (N=500) and for pediatric patients post-Fontan procedure (N=110)4-8